Effect of IL-6 on the insulin sensitivity in patients with type 2 diabetes.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  American Journal of Physiology. Endocrinology and Metabolism

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1152/ajpendo.00571.2013PMID 24473436
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-6 promotes myogenic differentiation of mouse skeletal muscle cells: role of the STAT3 pathway.

  2013cited by this paper
• Altered Response of Skeletal Muscle to IL-6 in Type 2 Diabetic Patients

  2013cited by this paper
• Satellite Cells Derived from Obese Humans with Type 2 Diabetes and Differentiated into Myocytes In Vitro Exhibit Abnormal Response to IL-6

  2012cited by this paper
• Physiological concentrations of interleukin-6 directly promote insulin secretion, signal transduction, nitric oxide release, and redox status in a clonal pancreatic β-cell line and mouse islets.

  2012cited by this paper
• Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells

  2011cited by this paper
• Proteomic identification of secreted proteins from human skeletal muscle cells and expression in response to strength training.

  2011cited by this paper
• IL-6 selectively stimulates fat metabolism in human skeletal muscle.

  2010cited by this paper
• Interleukin-6 autoantibodies are involved in the pathogenesis of a subset of type 2 diabetes.

  2010cited by this paper
• Interleukin-6 Attenuates Insulin-Mediated Increases in Endothelial Cell Signaling but Augments Skeletal Muscle Insulin Action via Differential Effects on Tumor Necrosis Factor-α Expression

  2009cited by this paper
• The diseasome of physical inactivity – and the role of myokines in muscle–fat cross talk

  2009cited by this paper
• Comparative proteomic analysis of the insulin‐induced L6 myotube secretome

  2009cited by this paper
• "Sick fat," metabolic disease, and atherosclerosis.

  2009cited by this paper
• Dual Role of Interleukin-6 in Regulating Insulin Sensitivity in Murine Skeletal Muscle

  2008cited by this paper
• Interleukin-6 markedly decreases skeletal muscle protein turnover and increases nonmuscle amino acid utilization in healthy individuals.

  2008cited by this paper
• Cardiovascular Risk Factors, Mortality, and Overweight—Reply

  2008cited by this paper
• Metabolic responses to reduced daily steps in healthy nonexercising men.

  2008cited by this paper
• Interleukin-6 Directly Increases Glucose Metabolism in Resting Human Skeletal Muscle

  2007cited by this paper
• Influence of TNF-α and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans

  2006cited by this paper
• Interleukin-6 Increases Insulin-Stimulated Glucose Disposal in Humans and Glucose Uptake and Fatty Acid Oxidation In Vitro via AMP-Activated Protein Kinase

  2006cited by this paper
• Influence of TNF-alpha and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans.

  2006cited by this paper
• Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle.

  2006cited by this paper
• Interleukin-6 in acute exercise and training: what is the biological relevance?

  2006cited by this paper
• Computational reconstruction of the human skeletal muscle secretome

  2005cited by this paper
• Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation.

  2005cited by this paper
• Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro.

  2005cited by this paper
• Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction.

  2004cited by this paper
• Supplementation with vitamins C and E inhibits the release of interleukin‐6 from contracting human skeletal muscle

  2004cited by this paper
• Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.

  2003cited by this paper
• Acute interleukin‐6 administration does not impair muscle glucose uptake or whole‐body glucose disposal in healthy humans

  2003cited by this paper
• IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans.

  2003cited by this paper
• Interleukin-6 stimulates lipolysis and fat oxidation in humans.

  2003cited by this paper
• Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

  2001cited by this paper
• Production of interleukin‐6 in contracting human skeletal muscles can account for the exercise‐induced increase in plasma interleukin‐6

  2000cited by this paper
• Dose-dependent effects of recombinant human interleukin-6 on glucose regulation.

  1997cited by this paper
• Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure.

  1997cited by this paper
• Endocrinologic and metabolic effects of interleukin-6 in humans.

  1995cited by this paper
• Endocrine and carbohydrate responses to interleukin-6 in vivo.

  1994cited by this paper
• Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans

  1994cited by this paper
• Anti‐Interleukin‐6 Antibodies in Normal Human Serum

  1991cited by this paper
• Increased plasma levels of interleukin-6 in sepsis [see comments]

  1989cited by this paper
• Increased plasma levels of interleukin-6 in sepsis.

  1989cited by this paper
• The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera.

  1984cited by this paper
• An enzymic method for measurement of glycogen.

  1967cited by this paper
• MUSCLE ELECTROLYTES IN MAN DETERMINED BY NEUTRON ACTIVATION ANALYSIS ON NEEDLE BIOPSY SPECIMENS

  1962cited by this paper

• Myokines as potential mediators of changes in glucose homeostasis and muscle mass after bariatric surgery

  2025cites this paper
• Evaluation of renal and inflammatory markers in elderly diabetic patients in Port Harcourt

  2025cites this paper
• Exploring the Role of Acute Exercise-Induced Myokine Release in Glucose Metabolism and Insulin Sensitivity in Healthy and Diabetic Individuals

  2025cites this paper
• The impact of ageing mechanisms on musculoskeletal system diseases in the elderly

  2024cites this paper
• IL-6 and diabetic kidney disease

  2024cites this paper
• Role of Myokines and prospects for their role in Diabetes Mellitus Therapy

  2024cites this paper
• Tyrosol-loaded Nano-niosomes Attenuate Diabetic Injury by Targeting Glucose Metabolism, Inflammation, and Glucose Transfer.

  2023cites this paper
• Sex differences in systemic inflammation and immune function in diet‐induced obesity rodent models: A systematic review

  2023cites this paper
• Differential Roles of Interleukin-6 in Severe Acute Respiratory Syndrome-Coronavirus-2 Infection and Cardiometabolic Diseases.

  2023cites this paper
• Blocking TNF signaling may save lives in COVID-19 infection

  2022cites this paper
• Metabolic syndrome and possible treatments (consecutive therapies): a literature review

  2022cites this paper
• Adipokines from white adipose tissue in regulation of whole body energy homeostasis.

  2022cites this paper
• Factors mediating exercise‐induced organ crosstalk

  2022cites this paper
• Anti- and non-tumor necrosis factor-α-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

  2021cites this paper
• Cord Blood from SGA Preterm Infants Exhibits Increased GLUT4 mRNA Expression.

  2021cites this paper
• Insulin resistance and insulin sensitizing agents.

  2021cites this paper
• Trans-ethnic gut microbial signatures of prediabetic subjects from India and Denmark

  2021cites this paper
• The Clinical Utility of Salivary Biomarkers in the Identification of Type 2 Diabetes Risk and Metabolic Syndrome

  2020cites this paper
• DMSO_A_265879 3587..3599

  2020cites this paper
• The controversial role of IL-6 in adipose tissue on obesity-induced dysregulation of glucose metabolism.

  2020cites this paper
• Effect of rosiglitazone on inflammatory cytokines and oxidative stress after intensive insulin therapy in patients with newly diagnosed type 2 diabetes

  2019cites this paper
• RELATIONSHIP BETWEEN HBA1C LEVELS AND INFLAMMATORY BIOMARKERS (C - REACTIVE PROTEIN, IL6 AND TNF-ALPHA) AMONG TYPE 2 DIABETES MELLITUS-KHARTOUM- SUDAN

  2019cites this paper
• The role of interleukin-6 in glucose homeostasis and lipid metabolism

  2019cites this paper
• Physiology of the Incretin Hormones, GIP and GLP-1-Regulation of Release and Posttranslational Modifications.

  2019cites this paper
• Thioredoxin, thioredoxin interacting protein and transducer and activator of transcription 3 in gestational diabetes

  2019cites this paper
• Dietary Flavonoids in the Prevention of T2D: An Overview

  2018influential citation
• Physiological adaptations in ultra‐endurance athletes during a 5‐day multisport Adventure Race: An assessment of serological and inflammatory cytokine profiles

  2018cites this paper
• Icariin Ameliorates Palmitate-Induced Insulin Resistance Through Reducing Thioredoxin-Interacting Protein (TXNIP) and Suppressing ER Stress in C2C12 Myotubes

  2018cites this paper
• The study of the serum level of IL‐4, TGF‐β, IFN‐γ, and IL‐6 in overweight patients with and without diabetes mellitus and hypertension

  2018cites this paper
• Acute administration of interleukin‐6 does not increase secretion of glucagon‐like peptide‐1 in mice

  2018influential citation
• Intact regulation of muscle expression and circulating levels of myokines in response to exercise in patients with type 2 diabetes

  2018cites this paper
• Effect of exercise on acute postprandial glucose concentrations and interleukin-6 responses in sedentary and overweight males.

  2018cites this paper
• The KCNQ1 gene polymorphism as a shared genetic risk for rheumatoid arthritis and chronic periodontitis in Japanese adults: A pilot case‐control study

  2018cites this paper
• The role of exercise in glycaemic control and inflammation in overweight/obese individuals with and without type 2 diabetes

  2018cites this paper
• Interleukin-6 Delays Gastric Emptying in Humans with Direct Effects on Glycemic Control.

  2018cites this paper
• Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy

  2017cites this paper
• Elevated C-reactive protein, interleukin 6, tumor necrosis factor alpha and glycemic load associated with type 2 diabetes mellitus in rural Thais: a cross-sectional study

  2017cites this paper
• Investigating the role of immune-endocrine alterations during type 2 diabetes associated with changes in Mycobacterium tuberculosis growth

  2017cites this paper
• Estratégias para as opções dietéticas de combate à obesidade relacionadas com a morbilidade cardiometabolica

  2017influential citation
• The Potential Role of Contraction-Induced Myokines in the Regulation of Metabolic Function for the Prevention and Treatment of Type 2 Diabetes

  2017cites this paper
• Interleukin-6 is a negative regulator of hepatic glucose production in the isolated rat liver

  2016cites this paper
• Diabesity Increases Inflammation and Oxidative Stress

  2016cites this paper
• CCAAT/Enhancer Binding Protein β in relation to ER Stress, Inflammation, and Metabolic Disturbances

  2015cites this paper
• Cellular senescence in aging and age-related disease: from mechanisms to therapy

  2015cites this paper
• Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease

  2015cites this paper
• Human skeletal myotubes display a cell-autonomous circadian clock implicated in basal myokine secretion

  2015cites this paper
• Muscle-specific inflammation induced by MCP-1 overexpression does not affect whole-body insulin sensitivity in mice

  2015cites this paper
• Myokines and Metabolism

  2015cites this paper
• Targeting Inflammation Through a Physical Active Lifestyle and Pharmaceuticals for the Treatment of Type 2 Diabetes

  2015cites this paper
• From cytokine to myokine: the emerging role of interleukin‐6 in metabolic regulation

  2014cites this paper
• World Journal of Diabetes

  year unknowncites this paper